SCHEMBL23940707

SCHEMBL23940707

OC(CCNCc1ccccc1)C1CCc2cc(F)ccc2O1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 11/20 0.65
DRD3 P35462 10/20 0.65
HTR2A P28223 2/20 0.65
HTR2C P28335 2/20 0.65
HTR1A P08908 2/20 0.65
MLNR O43193 1/20 0.65
ADRB2 P07550 1/20 0.65
ADRB1 P08588 1/20 0.65
ADRA2A P08913 1/20 0.65
ADORA3 P0DMS8 1/20 0.65
CHRM1 P11229 1/20 0.65
KCNE1 P15382 1/20 0.65
ADRA2B P18089 1/20 0.65
ADRA2C P18825 1/20 0.65
CNR1 P21554 1/20 0.65
SLC6A2 P23975 1/20 0.65
NPY1R P25929 1/20 0.65
AVPR2 P30518 1/20 0.65
SLC6A4 P31645 1/20 0.65
ADRA1A P35348 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30080992 0.89 DRD2 (0.78) DRD2DRD3HTR2AHTR2CHTR1A
SCHEMBL2555127 0.89 DRD2 (0.78) DRD2DRD3HTR2AHTR2CHTR1A
SCHEMBL2283840 0.89 DRD2 (0.78) DRD2DRD3HTR2AHTR2CHTR1A
SCHEMBL2281292 0.89 DRD2 (0.78) DRD2DRD3HTR2AHTR2CHTR1A
SCHEMBL2289517 0.89 DRD2 (0.78) DRD2DRD3HTR2AHTR2CHTR1A
SCHEMBL2258387 0.89 DRD2 (0.78) DRD2DRD3HTR2AHTR2CHTR1A
SCHEMBL1737105 0.89 DRD2 (0.78) DRD2DRD3HTR2AHTR2CHTR1A
SCHEMBL2281287 0.89 DRD2 (0.78) DRD2DRD3HTR2AHTR2CHTR1A
SCHEMBL4459884 0.89 DRD2 (0.78) DRD2DRD3HTR2AHTR2CHTR1A
SCHEMBL4558134 0.89 DRD2 (0.78) DRD2DRD3HTR2AHTR2CHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3299364-B1 NEBIVOLOL SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF ZHEJIANG AUSUN PHARMACEUTICAL CO LTD (CN) 2021-10-20 EP disclosed